Wellgistics Health, Inc.
WGRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $8 | $11 | -$16 |
| % Growth | -61.3% | -28.3% | 167.7% | – |
| Cost of Goods Sold | $3 | $7 | $10 | -$15 |
| Gross Profit | $0 | $1 | $1 | -$1 |
| % Margin | 7.7% | 6.5% | 6.4% | 7.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $30 | $5 | $31 | $1 |
| SG&A Expenses | $31 | $5 | $31 | $1 |
| Sales & Mktg Exp. | $1 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | $1 | -$2 |
| Operating Expenses | $31 | $6 | $32 | -$2 |
| Operating Income | -$32 | -$6 | -$31 | $1 |
| % Margin | -1,047.1% | -70.6% | -288.6% | -3.3% |
| Other Income/Exp. Net | -$3 | -$1 | -$1 | -$0 |
| Pre-Tax Income | -$34 | -$7 | -$32 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$34 | -$7 | -$32 | $0 |
| % Margin | -1,139% | -85.6% | -298.5% | -2.2% |
| EPS | -0.46 | -0.11 | -0.62 | -0.083 |
| % Growth | -318.2% | 82.3% | -643.4% | – |
| EPS Diluted | -0.46 | -0.11 | -0.62 | -0.083 |
| Weighted Avg Shares Out | 74 | 62 | 52 | 52 |
| Weighted Avg Shares Out Dil | 74 | 62 | 52 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | -$0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$31 | -$5 | -$31 | $1 |
| % Margin | -1,020.5% | -60.1% | -281.1% | -4.1% |